Interactive 3D Complements in Proteopedia: Difference between revisions

Joel L. Sussman (talk | contribs)
Joel L. Sussman (talk | contribs)
Line 17: Line 17:
* The publication of [[3btp]] in ''Proc. Natl. Acad. Sci. USA'' (2008)<ref>PMID:18678909</ref> was accompanied by an I3DC.
* The publication of [[3btp]] in ''Proc. Natl. Acad. Sci. USA'' (2008)<ref>PMID:18678909</ref> was accompanied by an I3DC.
* The publication of "Structural linkage between ligand discrimination and receptor activation by type I interferon" in ''Cell'' (2011)<ref>PMID: 21854986</ref> was accompanied by an I3DC at [[Journal:Cell:1]]. The structures in the paper were  of interferon and interferon receptor complexes:  [[3s98]] (IFNAR1ΔSD4), [[3s8w]] (IFNAR2-D2), [[3s9d]] (binary IFNα-IFNAR2 complex), [[3se4]] (ternary IFNω complex), and [[3se3]] (ternary IFNα complex).
* The publication of "Structural linkage between ligand discrimination and receptor activation by type I interferon" in ''Cell'' (2011)<ref>PMID: 21854986</ref> was accompanied by an I3DC at [[Journal:Cell:1]]. The structures in the paper were  of interferon and interferon receptor complexes:  [[3s98]] (IFNAR1ΔSD4), [[3s8w]] (IFNAR2-D2), [[3s9d]] (binary IFNα-IFNAR2 complex), [[3se4]] (ternary IFNω complex), and [[3se3]] (ternary IFNα complex).
* The publication of "Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates" in ''PLoS ONE'' <ref>DOI 10.1371/journal.pone.0018360</ref>(2011) was accompanied by an I3DC at [[Journal:PLoS_ONE:1]].
* The publication of "Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates" in ''PLoS ONE'' <ref>DOI 10.1371/journal.pone.0018360</ref>(2011) was accompanied by an I3DC at [[Journal:PLoS_ONE:1]].


==I3DC vs. Supplementary Materials==
==I3DC vs. Supplementary Materials==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Jaime Prilusky, David Canner, Eric Martz, Joel L. Sussman